What is the average price target for ALBEMARLE CORP (ALB) stock?
30 analysts have analysed ALB and the average price target is 194.48 USD. This implies a price increase of 8.33% is expected in the next year compared to the current price of 179.53.
NYSE:ALB • US0126531013
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ALBEMARLE CORP (ALB).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-02-18 | Evercore ISI Group | Maintains | In-Line -> In-Line |
| 2026-02-17 | RBC Capital | Maintains | Outperform -> Outperform |
| 2026-02-17 | B of A Securities | Upgrade | Neutral -> Buy |
| 2026-02-13 | Citigroup | Maintains | Neutral -> Neutral |
| 2026-02-12 | Mizuho | Maintains | Neutral -> Neutral |
| 2026-01-28 | JP Morgan | Maintains | Neutral -> Neutral |
| 2026-01-28 | Jefferies | Maintains | Buy -> Buy |
| 2026-01-26 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2026-01-21 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2026-01-21 | Truist Securities | Upgrade | Hold -> Buy |
| 2026-01-21 | Citigroup | Maintains | Neutral -> Neutral |
| 2026-01-13 | Deutsche Bank | Upgrade | Hold -> Buy |
| 2026-01-12 | Mizuho | Maintains | Neutral -> Neutral |
| 2026-01-12 | ScotiaBank | Upgrade | Sector Perform -> Sector Outperform |
| 2026-01-12 | UBS | Maintains | Buy -> Buy |
| 2026-01-07 | Baird | Upgrade | Neutral -> Outperform |
| 2026-01-06 | Jefferies | Maintains | Buy -> Buy |
| 2025-12-19 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-12-18 | Mizuho | Maintains | Neutral -> Neutral |
| 2025-12-18 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-12-05 | UBS | Upgrade | Neutral -> Buy |
| 2025-12-03 | Deutsche Bank | Maintains | Hold -> Hold |
| 2025-12-02 | Baird | Upgrade | Underperform -> Neutral |
| 2025-11-19 | BMO Capital | Maintains | Outperform -> Outperform |
| 2025-11-13 | Mizuho | Maintains | Neutral -> Neutral |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 9.617B 31.38% | 5.378B -44.08% | 5.143B -4.37% | 5.692B 10.68% | 6.023B 5.82% | 6.52B 8.25% | 7.936B 21.72% | 8.766B 10.46% | 9.962B 13.64% | 10.351B 3.90% | 8.653B -16.40% | |
| EBITDA YoY % growth | 889.2M -68.28% | -40.668M -104.57% | 741.466M 1,923.22% | 2.145B 189.29% | 2.389B 11.38% | 2.583B 8.12% | 4.453B 72.40% | 4.69B 5.32% | 5.518B 17.65% | 5.749B 4.19% | 3.933B -31.59% | |
| EBIT YoY % growth | 459.256M -81.65% | -629.306M -237.03% | 82.788M 113.16% | 743.61M 798.21% | 1.028B 38.24% | 1.323B 28.70% | 1.798B 35.90% | 2.351B 30.76% | N/A | N/A | N/A | |
| Operating Margin | 4.78% | -11.70% | 1.61% | 13.06% | 17.07% | 20.29% | 22.66% | 26.82% | N/A | N/A | N/A | |
| EPS YoY % growth | 22.24 1.32% | -2.34 -110.52% | -0.79 66.24% | 7.52 1,051.57% | 8.83 17.53% | 10.71 21.28% | 17.26 61.10% | 20.19 16.97% | 31.28 54.93% | 31.98 2.23% | 20.75 -35.12% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | Q4 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.96 632.95% | 1.90 1,624.83% | 2.33 1,324.61% | 2.32 536.80% | 2.21 130.07% | 2.86 50.50% | 2.73 17.36% | 2.65 14.32% | 3.65 65.20% | 4.20 47.14% | 3.72 36.11% | 3.52 33.19% |
| Revenue Q2Q % growth | 1.312B 21.83% | 1.417B 6.54% | 1.486B 13.62% | 1.505B 5.39% | 1.526B 16.31% | 1.8B 27.03% | 1.702B 14.54% | 1.625B 7.97% | 1.768B 15.86% | 1.966B 9.22% | 1.806B 6.11% | 1.742B 7.20% |
| EBITDA Q2Q % growth | 432.73M 141.35% | 571.69M 51.35% | 613.32M 31.61% | 627.44M -9.27% | 591.58M 36.71% | 640.03M 11.95% | 618.25M 0.80% | 599.69M -4.42% | 898.58M 51.89% | 996.34M 55.67% | 902.47M 45.97% | 861.12M 43.59% |
| EBIT Q2Q % growth | 99.209M 465.68% | 192.39M 307.23% | 259.14M 994.88% | 254.23M 673.56% | 469.8M 373.55% | 568.11M 195.29% | 348.39M 34.44% | 526.62M 107.14% | 404.89M -13.82% | 502.66M -11.52% | 408.78M 17.33% | 367.42M -30.23% |
All data in USD
30 analysts have analysed ALB and the average price target is 194.48 USD. This implies a price increase of 8.33% is expected in the next year compared to the current price of 179.53.
ALBEMARLE CORP (ALB) will report earnings on 2026-04-28, after the market close.
The consensus EPS estimate for the next earnings of ALBEMARLE CORP (ALB) is 0.96 USD and the consensus revenue estimate is 1.31B USD.
The number of analysts covering ALBEMARLE CORP (ALB) is 30.